Pneumabort-K+1b

Company: Zoetis

Equine Rhinopneumonitis Vaccine

Killed Virus

This product has been shown to be effective for the vaccination of healthy horses 9 months of age or older, including pregnant mares, against respiratory disease caused by equine herpesvirus (EHV) types 1p and 1b virus and abortion due to EHV type 1 virus. Duration of immunity has not been established. For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov.

Dosage and Administration

For pregnant mares, shake well and aseptically administer one 2-mL dose intramuscularly during the 5th, 7th, and 9th month of pregnancy.

For young horses, shake well and aseptically administer one 2-mL dose intramuscularly after weaning, followed by a second 2-mL dose 3-4 weeks later. To ensure proper placement and retention of the vaccine, inject deep into the heavy muscles of the hindquarter. Mild exercise to promote absorption is recommended for 1 week after injection.

Precautions

Store at 2°-8°C. Prolonged exposure to higher temperatures and/or direct sunlight may adversely affect potency. Do not freeze. Occasional local swelling or induration at the site of injection may occur. Do not vaccinate within 60 days before slaughter. Contains thimerosal, neomycin, polymyxin B, and amphotericin B as preservatives. Do not mix with other products. In case of human exposure, contact a physician.

Technical inquiries should be directed to Zoetis Inc.

Veterinary Services, (888) 963-8471.

For Veterinary Use Only

Remove serial number and expiration date label and place on the animal’s medical chart.

VLN 190/PCN 1525.21

Zoetis Inc.

Kalamazoo, MI 49007, USA

CPN: 3690382.2